Abstract
Improved risk stratification and prognosis prediction in sepsis is a critical unmet need. Clinical severity scores and available assays such as blood lactate reflect global illness severity with suboptimal performance, and do not specifically reveal the underlying dysregulation of sepsis. Here, we present prognostic models for 30-day mortality generated independently by three scientific groups by using 12 discovery cohorts containing transcriptomic data collected from primarily community-onset sepsis patients. Predictive performance is validated in five cohorts of community-onset sepsis patients in which the models show summary AUROCs ranging from 0.765-0.89. Similar performance is observed in four cohorts of hospital-acquired sepsis. Combining the new gene-expression-based prognostic models with prior clinical severity scores leads to significant improvement in prediction of 30-day mortality as measured via AUROC and net reclassification improvement index These models provide an opportunity to develop molecular bedside tests that may improve risk stratification and mortality prediction in patients with sepsis.
Original language | English (US) |
---|---|
Article number | 694 |
Pages (from-to) | 694 |
Journal | Nature Communications |
Volume | 9 |
Issue number | 1 |
DOIs | |
State | Published - Feb 15 2018 |
Keywords
- Biomarkers/blood
- Community-Acquired Infections/mortality
- Cross Infection/mortality
- Gene Expression Profiling
- Humans
- Models, Theoretical
- Prognosis
- Sepsis/blood
- Severity of Illness Index
ASJC Scopus subject areas
- Physics and Astronomy(all)
- Chemistry(all)
- Biochemistry, Genetics and Molecular Biology(all)